SOLID TUMOR MALIGNANCY
Clinical trials for SOLID TUMOR MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMOR MALIGNANCY trials appear
Sign up with your email to follow new studies for SOLID TUMOR MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a new treatment where a patient's own immune cells are modified in a lab to better recognize and attack cancer cells that carry a protein called GPC3. The study includes 38 adults with advanced solid tumors, such as liver cancer, who have not responde…
Matched conditions: SOLID TUMOR MALIGNANCY
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New Dual-Action drug targets Hard-to-Treat tumors
Disease control Recruiting nowThis early-stage study tests a new drug that can both image and treat advanced solid tumors. The drug targets a protein called FAP found on many cancer cells. The trial involves 132 adults with advanced solid tumors who have not responded to standard treatments. The main goals ar…
Matched conditions: SOLID TUMOR MALIGNANCY
Phase: PHASE1 • Sponsor: Chengdu New Radiomedicine Technology Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug SIBP-A18 enters human testing for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug called SIBP-A18 in 156 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Participants receive the drug and a…
Matched conditions: SOLID TUMOR MALIGNANCY
Phase: PHASE1 • Sponsor: Shanghai Institute Of Biological Products • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC